Molecular basis of early stages of Clostridium difficile infection: Germination and colonization

Future Microbiology

Volumn 7, Issue 8, 2012, Pages 933-943

  Sarker, Mahfuzur R ^a   Paredes Sabja, Daniel ^a,b  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

Author keywords

CDI germination; Clostridium difficile; colonization

Indexed keywords

BILE SALT; GALLIDERMIN; NISIN; POLYMYXIN B; VANCOMYCIN;

ADAPTIVE IMMUNITY; AEROMONAS PUNCTATA; BACILLUS SUBTILIS; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL SPORE; CAMPYLOBACTER JEJUNI; CELL ADHESION; CELL STRAIN CACO 2; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CLOSTRIDIUM PERFRINGENS; COLON MUCOSA; CYTOPLASM; ELECTRON TRANSPORT; EXTRACELLULAR MATRIX; HELICOBACTER PYLORI; HUMAN; HYDROLYSIS; IMMUNE SYSTEM; IMMUNOELECTRON MICROSCOPY; INNATE IMMUNITY; INTESTINE FLORA; LEGIONELLA PNEUMOPHILA; MACROPHAGE; METABOLISM; MOLECULAR WEIGHT; NEUTROPHIL; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; HUMANS; SPORES, BACTERIAL;

CLOSTRIDIUM DIFFICILE;

EID: 84865593433     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.64     Document Type: Review

References (103)

1. Deneve C, Janoir C, Poilane I, Fantinato C, Collignon A. New trends in Clostridium difficile virulence and pathogenesis. Int. J. Antimicrob. Agents 33(Suppl. 1), S24-S28 (2009
2. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin. Microbiol. Infect. 12(Suppl. 6), 2-18 (2006
3. Borgmann S, Kist M, Jakobiak T et al. Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro Surveill. 13(49), (2008
4. Herrera P, Cotera A, Fica A, Galdo T, Alvo M. [High incidence and complications of Clostridium difficile diarrhea among patients with renal diseases]. Rev. Med. Chil. 131(4), 397-403 (2003
5. Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J. Gastroenterol. 15(13), 1554-1580 (2009
6. Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353(23), 2442-2449 (2005
7. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostrdium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg. Infect. Dis. 14, 929-931 (2008
8. Karas JA, Enoch DA, Aliyu SH. A review of mortality due to Clostridium difficile infection. J. Infect. 61(1), 1-8 (2010
9. Mcfarland LV. Alternative treatments for Clostridium difficile disease: what really works? J. Med. Microbiol. 54(Pt 2), 101-111 (2005
10. Mcfarland LV, Surawicz CM, Greenberg RN et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271(24), 1913-1918 (1994
11. Mcfarland LV, Elmer GW, Surawicz CM. Breaking the cycle: Treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am. J. Gastroenterol. 97(7), 1769-1775 (2002
12. Baines SD, O'Connor R, Saxton K, Freeman J, Wilcox MH. Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model. J. Antimicrob. Chemother. 63(3), 520-525 (2009
13. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocominal Clostridium difficile-associated disease during epidemic caused by a hypervirulent strain in Quebec. CMAJ 173, 1037-1042 (2005
14. Pepin J, Saheb N, Coulombe MA et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: A cohort study during an epidemic in Quebec. Clin. Infect. Dis. 41, 1254-1260 (2005
15. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 7(7), 526-536 (2009
16. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467(7316), 711-713 (2010
17. Kuehne SA, Cartman ST, Minton NP. Both, toxin A and toxin B, are important in Clostridium difficile infection. Gut Microbes 2(4), (2011
18. Lyras D, O'Connor JR, Howarth PM et al. Toxin B is essential for virulence of Clostridium difficile. Nature 458(7242), 1176-1179 (2009
19. Carter GP, Awad MM, Kelly ML, Rood JI, Lyras D. TcdB or not TcdB: A tale of two Clostridium difficile toxins. Future Microbiol. 6, 121-123 (2011
20. Just I, Selzer J, Wilm M, Von Eichel-Streiber C, Mann M, Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375(6531), 500-503 (1995
21. Jank T, Giesemann T, Aktories K. Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and function. Glycobiology 17(4), 15R-22R (2007
22. Goncalves C, Decre D, Barbut F, Burghoffer B, Petit JC. Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile. J. Clin. Microbiol. 42(5), 1933-1939 (2004
23. Geric B, Carman RJ, Rupnik M et al. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J. Infect. Dis. 193(8), 1143-1150 (2006
24. Schwan C, Stecher B, Tzivelekidis T et al. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog. 5(10), e1000626 (2009
25. Goorhuis A, Bakker D, Corver J et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 47(9), 1162-1170 (2008
26. Vonberg RP, Kuijper EJ, Wilcox MH et al. Infection control measures to limit the spread of Clostridium difficile. Clin. Microbiol. Infect. 14(Suppl. 5), 2-20 (2008
27. Fawley WN, Underwood S, Freeman J et al. Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect. Control Hosp. Epidemiol. 28(8), 920-925 (2007
28. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin. Infect. Dis. 45(8), 992-998 (2007
29. Gerding DN, Muto CA, Owens RC Jr. Measures to control and prevent Clostridium difficile infection. Clin. Infect. Dis. 46(Suppl. 1), S43-S49 (2008
30. Jump RL, Pultz MJ, Donskey CJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: A potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob. Agents Chemother. 51(8), 2883-2887 (2007
31. Paredes-Sabja D, Setlow P, Sarker MR. Germination of spores of Bacillales and Clostridiales species: mechanisms and proteins involved. Trends Microbiol 19(2), 85-94 (2011
32. Setlow P. Spore germination. Curr. Opin. Microbiol. 6(6), 550-556 (2003
33. Wilson KH. Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J. Clin. Microbiol. 18(4), 1017-1019 (1983
34. Wilson KH, Kennedy MJ, Fekety FR. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J. Clin. Microbiol. 15(3), 443-446 (1982
35. Sorg JA, Sonenshein AL. Bile salts and glycine as co-germinants for Clostridium difficile spores. J. Bacteriol. 190(7), 2505-2512 (2008
36. Howerton A, Ramirez N, Abel-Santos E. Mapping interactions between germinants and Clostridium difficile spores. J. Bacteriol. 193(1), 274-282 (2011
37. Wheeldon L, Worthington T, Lambert P. Histidine acts as a co-germinant with glycine and taurocholate for Clostridium difficile spores. J. Appl. Microbiol. doi:10.1111/j.1365-2672.2011.04953.x (2011) (Epub ahead of print
38. Giel JL, Sorg JA, Sonenshein AL, Zhu J. Metabolism of bile salts in mice influences spore germination in Clostridium difficile. PLoS One 5(1), e8740 (2010
39. Sorg JA, Sonenshein AL. Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. J. Bacteriol. 191(3), 1115-1117 (2009
40. Sorg JA, Sonenshein AL. Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J. Bacteriol. 192(19), 4983-4990 (2010
41. Mallonee DH, Hylemon PB. Sequencing and expression of a gene encoding a bile acid transporter from Eubacterium sp. strain VPI 12708. J. Bacteriol. 178(24), 7053-7058 (1996
42. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47(2), 241-259 (2006
43. Heeg D, Burns DA, Cartman ST, Minton NP. Spores of Clostridium difficile clinical isolates display a diverse germination response to bile salts. PLoS One 7(2), e32381 (2012
44. Ramirez N, Liggins M, Abel-Santos E. Kinetic evidence for the presence of putative germination receptors in Clostridium difficile spores. J. Bacteriol. 192(16), 4215-4222 (2010
45. Sebaihia M, Wren BW, Mullany P et al. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38(7), 779-786 (2006
46. Moir A, Smith DA. The genetics of bacterial spore germination. Annu. Rev. Microbiol. 44, 531-553 (1990
47. Paredes-Sabja D, Sarker MR. Germination response of spores of the pathoenic bacetrium Clostridium perfringens and Clostridium difficile to cultured human epithelial cells. Anaerobe 17(2), 78-84 (2011
48. Burns DA, Heap JT, Minton NP. SleC is essential for germination of Clostridium difficile spores in nutrient-rich medium supplemented with the bile salt taurocholate. J. Bacteriol. 192(3), 657-664 (2010
49. Cartman ST, Minton NP. A mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile. Appl. Environ. Microbiol. 76(4), 1103-1109 (2010
50. Bernet-Camard MF, Coconnier MH, Hudault S, Servin AL. Differentiation-associated antimicrobial functions in human colon adenocarcinoma cell lines. Exp. Cell Res. 226(1), 80-89 (1996
51. Northfield TC, Mccoll I. Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestine. Gut 14(7), 513-518 (1973
52. Mekhjian HS, Phillips SF, Hofmann AF. Colonic absorption of unconjugated bile acids: perfusion studies in man. Dig. Dis. Sci. 24(7), 545-550 (1979
53. Janvilisri T, Scaria J, Chang YF. Transcriptional profiling of Clostridium difficile and Caco-2 cells during infection. J. Infect. Dis. 202(2), 282-290 (2010
54. Eveillard M, Fourel V, Barc MC et al. Identification and characterization of adhesive factors of Clostridium difficile involved in adhesion to human colonic enterocyte-like Caco-2 and mucus-secreting HT29 cells in culture. Mol. Microbiol. 7(3), 371-381 (1993
55. Cerquetti M, Serafino A, Sebastianelli A, Mastrantonio P. Binding of Clostridium difficile to Caco-2 epithelial cell line and to extracellular matrix proteins. FEMS Immunol. Med. Microbiol. 32(3), 211-218 (2002
56. Sara M, Sleytr UB. S-Layer proteins. J. Bacteriol. 182(4), 859-868 (2000
57. Cerquetti M, Molinari A, Sebastianelli A et al. Characterization of surface layer proteins from different Clostridium difficile clinical isolates. Microb. Pathog. 28(6), 363-372 (2000
58. Calabi E, Ward S, Wren B et al. Molecular characterization of the surface layer proteins from Clostridium difficile. Mol. Microbiol. 40(5), 1187-1199 (2001
59. Qazi O, Hitchen P, Tissot B et al. Mass spectrometric analysis of the S-layer proteins from Clostridium difficile demonstrates the absence of glycosylation. J. Mass Spectrom. 44(3), 368-374 (2009
60. Takeoka A, Takumi K, Koga T, Kawata T. Purification and characterization of S layer proteins from Clostridium difficile GAI 0714. J. Gen. Microbiol. 137(2), 261-267 (1991
61. Calabi E, Calabi F, Phillips AD, Fairweather NF. Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Infect. Immun. 70(10), 5770-5778 (2002
62. Fagan RP, Albesa-Jove D, Qazi O, Svergun DI, Brown KA, Fairweather NF. Structural insights into the molecular organization of the S-layer from Clostridium difficile. Mol Microbiol 71(5), 1308-1322 (2009
63. Spigaglia P, Barbanti F, Mastrantonio P. Surface layer protein A variant of Clostridium difficile PCR-ribotype 027. Emerg. Infect. Dis. 17(2), 317-319 (2011
64. Spigaglia P, Galeotti CL, Barbanti F, Scarselli M, Van Broeck J, Mastrantonio P. Clostridium difficile PCR-ribotypes 027 and 001 share common immunogenic properties of the low-molecular-weight (LMW) surface layer (S-layer) protein. J. Med. Microbiol. 60(Pt 8), 1168-1173 (2011
65. Maeda H. Role of microbial proteases in pathogenesis. Microbiol. Immunol. 40(10), 685-699 (1996
66. Matsumoto K. Role of bacterial proteases in pseudomonal and serratial keratitis. Biol. Chem. 385(11), 1007-1016 (2004
67. Savariau-Lacomme MP, Lebarbier C, Karjalainen T, Collignon A, Janoir C. Transcription and analysis of polymorphism in a cluster of genes encoding surface-associated proteins of Clostridium difficile. J. Bacteriol. 185(15), 4461-4470 (2003
68. Janoir C, Pechine S, Grosdidier C, Collignon A. Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins. J. Bacteriol. 189(20), 7174-7180 (2007
69. Kirby JM, Ahern H, Roberts AK et al. Cwp84, a surface-associated cysteine protease, plays a role in the maturation of the surface layer of Clostridium difficile. J. Biol. Chem. 284(50), 34666-34673 (2009
70. Fagan RP, Janoir C, Collignon A, Mastrantonio P, Poxton IR, Fairweather NF. A proposed nomenclature for cell wall proteins of Clostridium difficile. J. Med. Microbiol. 60(Pt 8), 1225-1228 (2011
71. Chapetonmontes D, Candela T, Collignon A, Janoir C. Localization of the Clostridium difficile cysteine protease Cwp84 and insights into its maturation process. J. Bacteriol. 193(19), 5314-5321 (2011
72. De La Riva L, Willing SE, Tate EW, Fairweather NF. Roles of cysteine proteases Cwp84 and Cwp13 in biogenesis of the cell wall of Clostridium difficile. J. Bacteriol. 193(13), 3276-3285 (2011
73. Reynolds CB, Emerson JE, De La Riva L, Fagan RP, Fairweather NF. The Clostridium difficile cell wall protein CwpV is antigenically variable between strains, but exhibits conserved aggregation-promoting function. PLoS Pathog. 7(4), e1002024 (2011
74. Emerson JE, Reynolds CB, Fagan RP, Shaw HA, Goulding D, Fairweather NF. A novel genetic switch controls phase variable expression of CwpV, a Clostridium difficile cell wall protein. Mol. Microbiol. 74(3), 541-556 (2009
75. Waligora AJ, Hennequin C, Mullany P, Bourlioux P, Collignon A, Karjalainen T. Characterization of a cell surface protein of Clostridium difficile with adhesive properties. Infect. Immun. 69(4), 2144-2153 (2001
76. Kuboniwa M, Amano A, Hashino E et al. Distinct roles of long/short fimbriae and gingipains in homotypic biofilm development by Porphyromonas gingivalis. BMC Microbiol. 9, 105 (2009
77. Lawley TD, Clare S, Walker AW et al. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect. Immun. 77(9), 3661-3669 (2009
78. Saujet L, Monot M, Dupuy B, Soutourina O, Martin-Verstraete I. The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile. J. Bacteriol. 193(13), 3186-3196 (2011
79. Hennequin C, Porcheray F, Waligora- Dupriet A et al. GroEL (Hsp60) of Clostridium difficile is involved in cell adherence. Microbiology 147(Pt 1), 87-96 (2001
80. Hennequin C, Collignon A, Karjalainen T. Analysis of expression of GroEL (Hsp60) of Clostridium difficile in response to stress. Microb. Pathog. 31(5), 255-260 (2001
81. Jain S, Graham C, Graham RL, Mcmullan G, Ternan NG. Quantitative proteomic analysis of the heat stress response in Clostridium difficile strain 630. J. Proteome Res. 10(9), 3880-3890 (2011
82. Tasteyre A, Barc MC, Collignon A, Boureau H, Karjalainen T. Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect. Immun. 69(12), 7937-7940 (2001
83. Twine SM, Reid CW, Aubry A et al. Motility and flagellar glycosylation in Clostridium difficile. J. Bacteriol. 191(22), 7050-7062 (2009
84. Dietrich C, Heuner K, Brand BC, Hacker J, Steinert M. Flagellum of Legionella pneumophila positively affects the early phase of infection of eukaryotic host cells. Infect. Immun. 69(4), 2116-2122 (2001
85. Grant CC, Konkel ME, Cieplak W Jr, Tompkins LS. Role of flagella in adherence, internalization, and translocation of Campylobacter jejuni in nonpolarized and polarized epithelial cell cultures. Infect. Immun. 61(5), 1764-1771 (1993
86. Mcsweegan E, Walker RI. Identification and characterization of two Campylobacter jejuni adhesins for cellular and mucous substrates. Infect. Immun. 53(1), 141-148 (1986
87. Eaton KA, Suerbaum S, Josenhans C, Krakowka S. Colonization of gnotobiotic piglets by Helicobacter pylori deficient in two flagellin genes. Infect. Immun. 64(7), 2445-2448 (1996
88. Rabaan AA, Gryllos I, Tomas JM, Shaw JG. Motility and the polar flagellum are required for Aeromonas caviae adherence to HEp-2 cells. Infect. Immun. 69(7), 4257-4267 (2001
89. Dingle TC, Mulvey GL, Armstrong GD. Mutagenic analysis of the Clostridium difficile flagellar proteins, FliC and FliD, and their contribution to virulence in hamsters. Infect Immun. 79(10), 4061-4067 (2011
90. Seddon SV, Hemingway I, Borriello SP. Hydrolytic enzyme production by Clostridium difficile and its relationship to toxin production and virulence in the hamster model. J. Med. Microbiol. 31(3), 169-174 (1990
91. Poilane I, Karjalainen T, Barc MC, Bourlioux P, Collignon A. Protease activity of Clostridium difficile strains. Can. J. Microbiol. 44(2), 157-161 (1998
92. Janvilisri T, Scaria J, Thompson AD et al. Microarray identification of Clostridium difficile core components and divergent regions associated with host origin. J. Bacteriol. 191(12), 3881-3891 (2009
93. Timpl R, Brown JC. Supramolecular assembly of basement membranes. Bioessays 18(2), 123-132 (1996
94. Henderson B, Nair S, Pallas J, Williams MA. Fibronectin: A multidomain host adhesin targeted by bacterial fibronectin-binding proteins. FEMS Microbiol. Rev. 35(1), 147-200 (2011
95. Courtney HS, Li Y, Dale JB, Hasty DL. Cloning, sequencing, and expression of a fibronectin/fibrinogen-binding protein from group A streptococci. Infect. Immun. 62(9), 3937-3946 (1994
96. Van Der Flier M, Chhun N, Wizemann TM, Min J, Mccarthy JB, Tuomanen EI. Adherence of Streptococcus pneumoniae to immobilized fibronectin. Infect. Immun. 63(11), 4317-4322 (1995
97. Hennequin C, Janoir C, Barc MC, Collignon A, Karjalainen T. Identification and characterization of a fibronectin-binding protein from Clostridium difficile. Microbiology 149(Pt 10), 2779-2787 (2003
98. Lin YP, Kuo CJ, Koleci X, Mcdonough SP, Chang YF. Manganese binds to Clostridium difficile Fbp68 and is essential for fibronectin binding. J. Biol. Chem. 286(5), 3957-3969 (2011
99. Barketi-Klai A, Hoys S, Lambert-Bordes S, Collignon A, Kansau I. Role of fibronectin binding protein A in Clostridium difficile intestinal colonization. J. Med. Microbiol. 60(Pt 8), 1155-1161 (2011
100. Van Der Woude MW, Baumler AJ. Phase and antigenic variation in bacteria. Clin. Microb. Rev. 17(3), 581-611 (2004
101. Ho TD, Ellermeier CD. PrsW is required for colonization, resistance to antimicrobial peptides, and expression of extracytoplasmic function sigma factors in Clostridium difficile. Infect. Immun. 79(8), 3229-3238 (2011
102. Mcbride SM, Sonenshein AL. The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile. Microbiology 157(Pt 5), 1457-1465 (2011
103. Hasegawa M, Yamazaki T, Kamada N et al. Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J. Immunol. 186(8), 4872-4880 (2011